Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000365 ( Pmc/Corpus ); précédent : 0003649; suivant : 0003660 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells</title>
<author>
<name sortKey="Kumaki, Yohichi" sort="Kumaki, Yohichi" uniqKey="Kumaki Y" first="Yohichi" last="Kumaki">Yohichi Kumaki</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Day, Craig W" sort="Day, Craig W" uniqKey="Day C" first="Craig W." last="Day">Craig W. Day</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wandersee, Miles K" sort="Wandersee, Miles K" uniqKey="Wandersee M" first="Miles K." last="Wandersee">Miles K. Wandersee</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Schow, Bradley P" sort="Schow, Bradley P" uniqKey="Schow B" first="Bradley P." last="Schow">Bradley P. Schow</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Madsen, Justin S" sort="Madsen, Justin S" uniqKey="Madsen J" first="Justin S." last="Madsen">Justin S. Madsen</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Grant, Dixon" sort="Grant, Dixon" uniqKey="Grant D" first="Dixon" last="Grant">Dixon Grant</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Blatt, Lawrence M" sort="Blatt, Lawrence M" uniqKey="Blatt L" first="Lawrence M." last="Blatt">Lawrence M. Blatt</name>
<affiliation>
<nlm:aff id="A2">Research Laboratories, InterMune Inc., Brisbane, San Diego, CA 94005, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L." last="Barnard">Dale L. Barnard</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">18406349</idno>
<idno type="pmc">2441846</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441846</idno>
<idno type="RBID">PMC:2441846</idno>
<idno type="doi">10.1016/j.bbrc.2008.04.006</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">000365</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000365</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells</title>
<author>
<name sortKey="Kumaki, Yohichi" sort="Kumaki, Yohichi" uniqKey="Kumaki Y" first="Yohichi" last="Kumaki">Yohichi Kumaki</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Day, Craig W" sort="Day, Craig W" uniqKey="Day C" first="Craig W." last="Day">Craig W. Day</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wandersee, Miles K" sort="Wandersee, Miles K" uniqKey="Wandersee M" first="Miles K." last="Wandersee">Miles K. Wandersee</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Schow, Bradley P" sort="Schow, Bradley P" uniqKey="Schow B" first="Bradley P." last="Schow">Bradley P. Schow</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Madsen, Justin S" sort="Madsen, Justin S" uniqKey="Madsen J" first="Justin S." last="Madsen">Justin S. Madsen</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Grant, Dixon" sort="Grant, Dixon" uniqKey="Grant D" first="Dixon" last="Grant">Dixon Grant</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Blatt, Lawrence M" sort="Blatt, Lawrence M" uniqKey="Blatt L" first="Lawrence M." last="Blatt">Lawrence M. Blatt</name>
<affiliation>
<nlm:aff id="A2">Research Laboratories, InterMune Inc., Brisbane, San Diego, CA 94005, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L." last="Barnard">Dale L. Barnard</name>
<affiliation>
<nlm:aff id="A1">Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="ISSN">0006-291X</idno>
<idno type="eISSN">1090-2104</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">The primary targets for SARS-CoV infection are the epithelial cells in the respiratory and intestinal tract. The angiotensin-converting enzyme 2 (ACE-2) has been identified as a functional receptor for SARS-CoV. ACE-2 has been shown to be expressed at the apical domain of polarized Calu-3 cells. In this report, interferon alfacon 1 was examined for inhibitory activities against SARS-CoV on human lung carcinoma epithelial Calu-3 cell line and the other three African green monkey kidney epithelial cell lines. Interferon alfacon 1 demonstrated significant antiviral activity in neutral red uptake assay and virus yield reduction assay. The data might provide an important insight into the mechanism of pathogenesis of SARS-CoV allowing further development of antiviral therapies for treating SARS infections.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0372516</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1008</journal-id>
<journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
<journal-title>Biochemical and biophysical research communications</journal-title>
<issn pub-type="ppub">0006-291X</issn>
<issn pub-type="epub">1090-2104</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">18406349</article-id>
<article-id pub-id-type="pmc">2441846</article-id>
<article-id pub-id-type="manuscript">NIHMS51641</article-id>
<article-id pub-id-type="doi">10.1016/j.bbrc.2008.04.006</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kumaki</surname>
<given-names>Yohichi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Day</surname>
<given-names>Craig W.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wandersee</surname>
<given-names>Miles K.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schow</surname>
<given-names>Bradley P.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madsen</surname>
<given-names>Justin S.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grant</surname>
<given-names>Dixon</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blatt</surname>
<given-names>Lawrence M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barnard</surname>
<given-names>Dale L.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, Utah 84322-5600, USA</aff>
<aff id="A2">
<label>b</label>
Research Laboratories, InterMune Inc., Brisbane, San Diego, CA 94005, USA</aff>
<author-notes>
<corresp id="cor1">
<label>*</label>
Corresponding author: Tel: 435-797-1885; Fax: 435-797-3959; Email:
<email>ykumaki@cc.usu.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>28</day>
<month>5</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>4</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="ppub">
<day>20</day>
<month>6</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>6</month>
<year>2009</year>
</pub-date>
<volume>371</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>113</lpage>
<abstract>
<p id="P1">The primary targets for SARS-CoV infection are the epithelial cells in the respiratory and intestinal tract. The angiotensin-converting enzyme 2 (ACE-2) has been identified as a functional receptor for SARS-CoV. ACE-2 has been shown to be expressed at the apical domain of polarized Calu-3 cells. In this report, interferon alfacon 1 was examined for inhibitory activities against SARS-CoV on human lung carcinoma epithelial Calu-3 cell line and the other three African green monkey kidney epithelial cell lines. Interferon alfacon 1 demonstrated significant antiviral activity in neutral red uptake assay and virus yield reduction assay. The data might provide an important insight into the mechanism of pathogenesis of SARS-CoV allowing further development of antiviral therapies for treating SARS infections.</p>
</abstract>
<kwd-group>
<kwd>angiotensin-converting enzyme 2</kwd>
<kwd>ACE-2</kwd>
<kwd>Calu-3 cells</kwd>
<kwd>IFN-alfacon 1</kwd>
<kwd>neutral red uptake assay</kwd>
<kwd>SARS-CoV</kwd>
<kwd>severe acute respiratory syndrome</kwd>
<kwd>virus yield reduction assay</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000365  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000365  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021